In the news
Takara Bio USA, Inc. (formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., develops, manufactures, and distributes a wide range of life science research reagents under the Takara, Clontech, and Cellartis brands. To keep you up to date with the latest happenings at Takara Bio USA, we have compiled our recent announcements and press releases below.
Takara Bio launches high-throughput, cost-effective qPCR system to advance clinical research
Date: November 19, 2024
Categories: Press release
Takara Bio USA announced the launch of the SmartChip ND Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for infectious disease research.
Takara Bio Europe unveils new large-scale NGS profiling system and chemistries
Date: September 26, 2024
Categories: Press release
Takara Bio Europe announces the launch of the Shasta Single-Cell System at the 2024 Human Cell Atlas General Meeting.
Takara Bio launches large-scale, flexible qPCR system to advance broad surveillance of antimicrobial resistance
Date: September 4, 2024
Categories: Press release
Takara Bio USA, Inc. announced the launch of the SmartChip ND Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for monitoring antimicrobial resistance (AMR), supporting efforts to ensure environmental safety and sustainability.
Jumpcode Genomics and Takara Bio USA announce global patent partnership
Date: June 13, 2024
Categories: Press release
Jumpcode Genomics and Takara Bio USA announced the companies have settled their patent dispute and have partnered to bring together their combined foundational IP in the field of targeted depletion of undesired transcripts such as ribosomal RNAs from NGS libraries using CRISPR-based technology.
Takara Bio launches first commercial dissolvable microfluidic lentiviral transduction enhancer
Date: May 6, 2024
Categories: Press release
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the Lenti-X Transduction Sponge, a first-to-market dissolvable microfluidic transduction enhancer that innovates in vitro lentivirus-mediated gene delivery techniques.
Launch of high-quality mutant T7 RNA polymerase suitable for mRNA vaccine and therapeutic development
Date: April 19, 2024
Categories: Press release
Takara Bio has released PrimeCap T7 RNA Polymerase (low dsRNA), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development, in March 2024.
Takara Bio transforms single-cell landscape with new large-scale NGS profiling system for oncology biomarker discovery
Date: April 2, 2024
Categories: Press release
Takara Bio USA, Inc. today announced the launch of the Shasta™ Single-Cell System, an automated, high-throughput NGS solution with well-validated chemistries and intuitive bioinformatics tools that enables novel biomarker discovery for oncology research.
Takara Bio’s first-to-market large-scale single-cell NGS profiling technologies poised to revolutionize biomarker discovery
Date: February 5, 2024
Categories: Press release
Takara Bio USA, Inc. announced plans to launch two critical solutions for oncology research. These automated single-cell total RNA-seq and DNA-seq library preparation kits will provide high sample and cell throughput, less hands-on time, and the ability to capture more information than other available technologies.
Takara Bio USA wins EU opposition hearing, revoking Jumpcode Genomics’ NGS library enrichment patent
Date: December 11, 2023
Categories: Press release
Takara Bio USA, Inc. today announced that it has once again prevailed in its second patent dispute with Jumpcode Genomics, Inc.
Takara Bio enters into a license agreement of RetroNectin with Fondazione Telethon ETS
Date: September 25, 2023
Categories: Announcement
Takara Bio Inc. announces that it has entered into a License Agreement with non-profit/charity organization, Fondazione Telethon ETS, Italy, under which Takara Bio grants Telethon a commercial license to use RetroNectin.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2024 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
